Skip to main content
Clinical Trials/NCT01782105
NCT01782105
Completed
N/A

Intervention en Changement Des Habitudes de Vie Par l'Activité Physique et un Support Nutritionnel Durant la Grossesse en Estrie

Université de Sherbrooke1 site in 1 country16 target enrollmentDecember 2011

Overview

Phase
N/A
Intervention
Not specified
Conditions
Excessive Weight Gain During Pregnancy
Sponsor
Université de Sherbrooke
Enrollment
16
Locations
1
Primary Endpoint
Weight change during pregnancy
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The purpose of this study are:

  • Assess the impact of an intervention to the adoption of healthy lifestyles among pregnant women at high risk of gestational diabetes mellitus on:

    • weight gain in pregnancy
    • the levels of maternal and fetal adipokines and
    • glycemic control maternal and fetal.
  • Determine whether the adoption of healthy lifestyles in pregnancy is associated with epigenetic changes that influence the levels of adipokines and glucose regulation during pregnancy and in newborns.

Registry
clinicaltrials.gov
Start Date
December 2011
End Date
October 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Marie-France Hivert

MD, MSc

Université de Sherbrooke

Eligibility Criteria

Inclusion Criteria

  • be aged ≥ 18 years,
  • have a pre-pregnancy BMI ≥ 25 kg/m2,
  • be at risk of developing a gestational diabetes mellitus (a history of gestational diabetes mellitus or glucose 1 hour post-50g \> 7.1 mmol/L.

Exclusion Criteria

  • Pre-pregnancy diabetes detected in the first trimester (A1c \> 6.5%, fasting glucose \> 7.0 mmol/L, random blood glucose\> 11.1 mmol/L, glucose \> 10.3 mmol/L 1 hour post-50g)
  • twin pregnancy
  • taking medications that can affect blood sugar or weight,
  • practice ≥ 150 minutes of physical activity per week
  • against formal-indication for physical activity.

Outcomes

Primary Outcomes

Weight change during pregnancy

Time Frame: Weeks 12, 24, 36 of gestation

Secondary Outcomes

  • Levels of maternal and fetal adipokines(Weeks 12, 24 of gestation and at delivery (in cord blood))
  • Maternal and fetal glycemic control(Weeks 12, 24 of gestation and at delivery)
  • Determine whether the adoption of healthy lifestyle in pregnancy is associated with epigenetic changes that influence the levels of adipokines and glucose regulation during pregnancy and in newborns.(Weeks 12, 24 of gestation and at delivery (cord blood))
  • Optimize the intervention before measuring its impact on the prevention of gestational diabetes mellitus on a larger scale.(throughout the study)

Study Sites (1)

Loading locations...

Similar Trials